Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino)pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies
Year: 2019
Type: article
Institutions: Zhejiang University, Yangtze River Pharmaceutical Group (China), Chinese Academy of Sciences, Shanghai Institute of Materia Medica, National Center for Drug Screening, University of Chinese Academy of Sciences, State Key Laboratory of Drug Research, ShanghaiTech University, Qingdao National Laboratory for Marine Science and Technology
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2934023391
